{
  "emaEpar": [],
  "fdaDrugLabel": [
    {
      "brand": "Tretinoin",
      "indication": "INDICATIONS AND USAGE Tretinoin Capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the PML/RAR\u03b1 gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline based chemotherapy is contraindicated. Tretinoin is for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for APL after completion of induction therapy with tretinoin.",
      "manufacturer": "Bryant Ranch Prepack",
      "splSetId": "00892887-ad81-414d-a388-08716235fa2c"
    },
    {
      "brand": "Tretinoin",
      "indication": "INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the PML/RAR\u03b1 gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for APL after completion of induction therapy with tretinoin capsules.",
      "manufacturer": "Major Pharmaceuticals",
      "splSetId": "045258e2-5efb-4147-bf74-4c43af04dccc"
    },
    {
      "brand": "Retin-A MICRO",
      "indication": "1 INDICATIONS AND USAGE Retin-A Micro \u00ae is a retinoid indicated for topical application in the treatment of acne vulgaris. Retin-A Micro is a retinoid, indicated for topical treatment of acne vulgaris. ( 1 )",
      "manufacturer": "Bausch Health US LLC",
      "splSetId": "08ab7e0c-1437-455f-815c-98904d96a289"
    },
    {
      "brand": "TRETINOIN",
      "indication": "Indications and Usage: Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.",
      "manufacturer": "A-S Medication Solutions",
      "splSetId": "0a6722ba-c2e5-4d7a-82ea-bcd6a54033b5"
    },
    {
      "brand": "VELTIN",
      "indication": "1 INDICATIONS AND USAGE VELTIN\u2122 (clindamycin phosphate and tretinoin) Gel, 1.2%/0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years and older. \u2022 VELTIN\u2122 Gel is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years and older. ( 1 )",
      "manufacturer": "Almirall, LLC",
      "splSetId": "0dad9bef-cfcc-4216-86c8-9ccd6b8613d8"
    },
    {
      "brand": "Tretinoin",
      "indication": "INDICATIONS AND USAGE Tretinoin Capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the PML/RAR\u03b1 gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline based chemotherapy is contraindicated. Tretinoin is for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for APL after completion of induction therapy with tretinoin.",
      "manufacturer": "Teva Pharmaceuticals USA, Inc.",
      "splSetId": "0f81f505-a962-414e-8612-c3ef3b159e9a"
    },
    {
      "brand": "Altreno",
      "indication": "1 INDICATIONS AND USAGE ALTRENO \u00ae (tretinoin) lotion, 0.05% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ALTRENO is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. (1)",
      "manufacturer": "Bausch Health US, LLC",
      "splSetId": "1412aba5-71aa-4cce-8db4-c189bed1852c"
    },
    {
      "brand": "Tretinoin",
      "indication": "INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the PML/RAR\u03b1 gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin is for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for APL after completion of induction therapy with tretinoin.",
      "manufacturer": "Glenmark Pharmaceuticals Inc., USA",
      "splSetId": "264138c1-9e5f-45ef-be87-79ca97c989d9"
    },
    {
      "brand": "Tretinoin",
      "indication": "Indications and Usage Tretinoin cream is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.",
      "manufacturer": "Taro Pharmaceuticals U.S.A., Inc.",
      "splSetId": "2b0c8ee4-83a5-48f1-809a-9716131f7290"
    },
    {
      "brand": "Avita",
      "indication": "INDICATIONS AND USAGE AVITA \u00ae Cream is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of this product in the treatment of other disorders have not been established.",
      "manufacturer": "Mylan Pharmaceuticals Inc.",
      "splSetId": "302ca95f-5a7e-4971-870a-5cfea618d7a7"
    },
    {
      "brand": "TRETINOIN",
      "indication": "Indications and Usage: Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.",
      "manufacturer": "Padagis US LLC",
      "splSetId": "4889c7f8-37d0-4f1a-9829-bca107806586"
    },
    {
      "brand": "Clindamycin Phosphate 1.2% and Tretinoin 0.025%",
      "indication": "1 INDICATIONS AND USAGE Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older. ( 1 )",
      "manufacturer": "Oceanside Pharmaceuticals",
      "splSetId": "63b2e85d-8fe5-4f18-9e85-8492c49a7520"
    },
    {
      "brand": "Avita",
      "indication": "INDICATIONS AND USAGE AVITA \u00ae Gel is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of this product in the treatment of other disorders have not been established.",
      "manufacturer": "Mylan Pharmaceuticals Inc.",
      "splSetId": "6bb07b84-68bd-4513-b0cf-e2e949eaa964"
    },
    {
      "brand": "Tretinoin",
      "indication": "INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the PML/RAR\u03b1 gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for APL after completion of induction therapy with tretinoin capsules.",
      "manufacturer": "AvKARE, Inc.",
      "splSetId": "6f8c2985-0241-5ebf-7ed4-4bd9a4ead9c9"
    },
    {
      "brand": "Tretinoin Cream",
      "indication": "INDICATIONS AND USAGE Tretinoin is indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.",
      "manufacturer": "Obagi Cosmeceuticals LLC",
      "splSetId": "745cc3ce-60b4-4479-a055-316817567949"
    },
    {
      "brand": "ZIANA",
      "indication": "1 INDICATIONS AND USAGE ZIANA Gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older. ZIANA \u00ae Gel is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older. ( 1 )",
      "manufacturer": "Bausch Health US, LLC",
      "splSetId": "78c329f9-f0c9-486d-9e54-0123699fb9e1"
    },
    {
      "brand": "Clindamycin Phosphate and Tretinoin",
      "indication": "1 INDICATIONS & USAGE Clindamycin phosphate and tretinoin gel 1.2% / 0.025% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. Clindamycin phosphate and tretinoin gel 1.2% / 0.025% is a lincosamide antibiotic and retinoid combination product indicated for the topical treatment of acne vulgaris in patients 12 years or older. ( 1 )",
      "manufacturer": "Actavis Pharma, Inc.",
      "splSetId": "79e1c8f6-59cd-4efa-9efa-0762d4b1a10c"
    },
    {
      "brand": "Tretinoin",
      "indication": "INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant), characterized by the presence of the t(15;17) translocation and/or the presence of the PML/RAR\u03b1 gene who are refractory to, or who have relapsed from, anthracycline chemotherapy, or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are for the induction of remission only. The optimal consolidation or maintenance regimens have not been defined, but all patients should receive an accepted form of remission consolidation and/or maintenance therapy for APL after completion of induction therapy with tretinoin capsules.",
      "manufacturer": "Bryant Ranch Prepack",
      "splSetId": "844941d4-f557-42cf-b7fa-5bd7574925f6"
    }
  ],
  "id": "Tretinoin",
  "nciThesaurus": {
    "casRegistry": "302-79-4",
    "chebiId": "CHEBI:15367",
    "chemicalFormula": "C20H28O2",
    "definition": "A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis.  This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types.  The oral form of tretinoin has teratogenic and embryotoxic properties.",
    "fdaUniiCode": "5688UTC01R",
    "identifier": "C900",
    "preferredName": "Tretinoin",
    "semanticType": "Organic Chemical",
    "subclassOf": [],
    "synonyms": [
      "(All-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid",
      "2,4,6,8-Nonatetraenoic acid, 3, 7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-",
      "ATRA",
      "Aberel",
      "Airol",
      "Aknoten",
      "All-trans Retinoic Acid",
      "All-trans Vitamin A Acid",
      "Avita",
      "Cordes Vas",
      "Dermairol",
      "Epi-Aberel",
      "Eudyna",
      "Renova",
      "Retin-A",
      "Retin-A MICRO",
      "Retin-A-Micro",
      "Retinoic Acid",
      "Retisol-A",
      "Ro 5488",
      "Stieva-A",
      "Stieva-A Forte",
      "TRETINOIN",
      "Trans Retinoic Acid",
      "Trans Vitamin A Acid",
      "Tretinoin",
      "Tretinoinum",
      "Vesanoid",
      "Vitamin A Acid",
      "Vitamin A acid",
      "Vitamin A acid, all-trans-",
      "Vitinoin",
      "all trans-Retinoic acid",
      "all-trans retinoic acid",
      "all-trans-Retinoic acid",
      "all-trans-Vitamin A acid",
      "beta-Retinoic Acid",
      "retinoic acid",
      "trans-Retinoic Acid",
      "trans-Retinoic acid",
      "tretinoin",
      "vitamin A acid"
    ]
  }
}